Stay informed and ready to meet both everyday challenges and long-term planning and policy-making goals, with focused news, practical information, and strategic insights on all HR-related developments.
March 14 — With a growing number of states having decriminalized marijuana, employers face some uncertainty on how to deal with the drug, attorney R. Scott Oswald, managing principal at the Employment Law Group, said March 14.
Speaking at the Society for Human Resource Management 2016 Employment Law & Legislative Conference in Washington, Oswald said an employer's approach depends on many factors.
“All over the country we have different laws that are applying at the state level, and for a multi-state employer it is enormously challenging,” he said. While the national conversation may be moving toward an increase in legalization of marijuana, he said, federal law still prohibits it.
According to Oswald, the bottom line in the workplace is that employers can continue to terminate employees for failing a drug test. In states where marijuana use is legal, he said, “decriminalization is a defense to criminal prosecution and not an affirmative right to use.”
Employers also will likely need to address whether they are willing to consider medical marijuana as a reasonable accommodation under the Americans with Disabilities Act, Oswald told conference attendees.
There are several medical conditions that are ameliorated or treatable with marijuana and qualify as disabilities under the ADA, he said. For example, he said, marijuana has proven effective for treating muscle spasms caused by multiple sclerosis; nausea from cancer chemotherapy; poor appetite and weight loss caused by chronic illness, such as HIV or nerve pain; seizure disorders; and Crohn’s disease.
“The key here is flexibility,” Oswald said, adding that employers will never have to allow for an employee who is impaired by drug use and can't perform his or her job.
For drug-testing policies in general, Oswald recommended the following:
Oswald noted that employers are generally free to set their own drug policies, whether zero tolerance or otherwise. If an employee contests the legitimacy of testing results, he recommended employers make sure they are partnered with an experienced and reputable drug-testing company so that all procedures are sure to be followed, including compliance with chain of custody, privacy and state and federal regulations.
Employers also should direct an employee contesting results to contact the third-party testing facility.
To contact the reporter on this story: Genevieve Douglas in Washington at firstname.lastname@example.org
To contact the editor responsible for this story: Tony Harris in Washington at email@example.com
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to firstname.lastname@example.org.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to email@example.com.
Put me on standing order
Notify me when new releases are available (no standing order will be created)